Figure 4 | Scientific Reports

Figure 4

From: An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy

Figure 4

BC-PDE proliferation responses to FET chemotherapy. (A)–(B) 46 BC-PDEs were treated with FET and percent change in proliferation/Ki67 positivity relative to vehicle control were calculated in tumour and stroma changes, respectively. † indicates PDEs from patients that have subsequently died and ° indicates PDEs from patients that have had a recurrence (Additional File 1).

Back to article page